Assessment of Breathlessness in Lung Cancer: Psychometric Properties of the Dyspnea-12 Questionnaire

Journal of Pain and Symptom Management

Volumn 53, Issue 2, 2017, Pages 208-215

  Tan, Jing Yu ^a,b   Yorke, Janelle ^a,c   Harle, Amelie ^c   Smith, Jacky ^d,e   Blackhall, Fiona ^c,e   Pilling, Mark ^a   Molassiotis, Alex ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Breathlessness; lung cancer; psychometrics; reliability; scale; validity

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTRUCT VALIDITY; CONVERGENT VALIDITY; DEPRESSION; DISEASE SEVERITY; DYSPNEA; DYSPNEA 12 QUESTIONNAIRE; EXPLORATORY FACTOR ANALYSIS; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG CANCER; LUNG CANCER SYMPTOM SCALE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUMERIC RATING SCALE; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RESPIRATORY TRACT DISEASE ASSESSMENT; VERY ELDERLY; YOUNG ADULT; COMPLICATION; LUNG TUMOR; PATHOPHYSIOLOGY; QUALITY OF LIFE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; DEPRESSION; DYSPNEA; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85006997533     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2016.08.009     Document Type: Article

References (44)

1. 1 American Thoracic Society. Dyspnea: mechanisms, assessment, and management. A consensus statement. Am J Respir Crit Care Med 159 (1999), 321–340.
2. 2 Smith, E.L., Hann, D.M., Ahles, T.A., et al. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage 21 (2001), 323–329.
3. 3 Molassiotis, A., Lowe, M., Blackhall, F., Lorigan, P., A qualitative exploration of a respiratory distress symptom cluster in lung cancer: cough, breathlessness and fatigue. Lung Cancer 71 (2011), 94–102.
4. 4 Dudgeon, D.J., Kristjanson, L., Sloan, J.A., Lertzman, M., Clement, K., Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage 21 (2001), 95–102.
5. 5 Iyer, S., Taylor-Stokes, G., Roughley, A., Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer 81 (2013), 288–293.
6. 6 Henoch, I., Bergman, B., Gustafsson, M., Gaston-Johansson, F., Danielson, E., Dyspnea experience in patients with lung cancer in palliative care. Eur J Oncol Nurs 12 (2008), 86–96.
7. 7 Parshall, M.B., Schwartzstein, R.M., Adams, L., et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185 (2012), 435–452.
8. 8 Bausewein, C., Farquhar, M., Booth, S., Gysels, M., Higginson, I.J., Measurement of breathlessness in advanced disease: a systematic review. Respir Med 101 (2007), 399–410.
9. 9 Johnson, M.J., Close, L., Gillon, S.C., et al. Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis. Eur Respir J 47 (2016), 1861–1864.
10. 10 Chhabra, S.K., Gupta, A.K., Khuma, M.Z., Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease. Ann Thorac Med 4 (2009), 128–132.
11. 11 Tanaka, K., Akechi, T., Okuyama, T., Nishiwaki, Y., Uchitomi, Y., Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale. Br J Cancer 82 (2000), 800–805.
12. 12 Uronis, H.E., Shelby, R.A., Currow, D.C., Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer. J Pain Symptom Manage 44 (2012), 741–749.
13. 13 Henoch, I., Bergman, B., Gaston-Johansson, F., Validation of a Swedish version of the Cancer Dyspnea Scale. J Pain Symptom Manage 31 (2006), 353–361.
14. 14 Dorman, S., Byrne, A., Edwards, A., Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 21 (2007), 1–27.
15. 15 Charalambous, A., Molassiotis, A., Preliminary validation and reliability of the Short Form Chronic Respiratory Disease Questionnaire in a lung cancer population. Eur J Cancer Care, 2015 Nov 20, 10.1111/ecc.12418 [Epub ahead of print].
16. 16 Guyatt, G.H., Berman, L.B., Townsend, M., Pugsley, S.O., Chambers, L.W., A measure of quality of life for clinical trials in chronic lung disease. Thorax 42 (1987), 773–778.
17. 17 Molen, B., Dyspnoea: a study of measurement instruments for the assessment of dyspnoea and their application for patients with advanced cancer. J Adv Nurs 22 (1995), 948–956.
18. 18 Corner, J., O'Driscoll, M., Development of a breathlessness assessment guide for use in palliative care. Palliat Med 13 (1999), 375–384.
19. 19 Al-Ghabeesh, S., Ahmad, M., Unidimentional and multidimensional breathlessness specific instruments for adult population: literature review. J Nat Sci Res 2 (2012), 1–15.
20. 20 Yorke, J., Moosavi, S.H., Shuldham, C., Jones, P.W., Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 65 (2010), 21–26.
21. 21 Yorke, J., Russell, A.M., Swigris, J., et al. Assessment of dyspnea in asthma: validation of the Dyspnea-12. J Asthma 48 (2011), 602–608.
22. 22 Yorke, J., Swigris, J., Russell, A.M., et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 139 (2011), 159–164.
23. 23 Yorke, J., Armstrong, I., The assessment of breathlessness in pulmonary arterial hypertension: reliability and validity of the Dyspnoea-12. Eur J Cardiovasc Nurs 13 (2014), 506–514.
24. 24 Yorke, J., Lloyd-Williams, M., Smith, J., et al. Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial. Support Care Cancer 23 (2015), 3373–3384.
25. 25 Farquhar, M.C., Prevost, A.T., McCrone, P., et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med, 12, 2014, 1.
26. 26 Barton, R., English, A., Nabb, S., Rigby, A.S., Johnson, M.J., A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study. Lung Cancer 70 (2010), 313–319.
27. 27 Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983), 361–370.
28. 28 Snaith, R.P., The hospital anxiety and depression scale. Health Qual Life Outcomes, 1, 2003, 29.
29. 29 Bjelland, I., Dahl, A.A., Haug, T.T., Neckelmann, D., The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52 (2002), 69–77.
30. 30 Hollen, P.J., Gralla, R.J., Kris, M.G., et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73 (1994), 2087–2098.
31. 31 Hollen, P.J., Gralla, R.J., Kris, M.G., Potanovich, L.M., Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A Suppl 1 (1993), S51–S58.
32. 32 Pérol, M., Ciuleanu, T.E., Arrieta, O., et al. Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy. Lung Cancer 93 (2016), 95–103.
33. 33 Bohrnstedt, G.W., A quick method for determining the reliability and validity of multiple-item scales. Am Sociol Rev 34 (1969), 542–548.
34. 34 Wahlqvist, P., Carlsson, J., Stålhammar, N.O., Wiklund, I., Validity of a Work Productivity and Activity Impairment Questionnaire for Patients with Symptoms of Gastro-Esophageal Reflux Disease (WPAI-GERD)—results from a cross-sectional study. Value Health 5 (2002), 106–113.
35. 35 DeVellis, R.F., Scale development: Theory and applications. 1991, Sage Publications, Newbury Park, CA.
36. 36 Altman, D.G., Practical statistics for medical research. 1991, Chapman and Hall, London, UK.
37. 37 Sarna, L., Evangelista, L., Tashkin, D., et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest 125 (2004), 439–445.
38. 38 Tanaka, K., Akechi, T., Okuyama, T., Nishiwaki, Y., Uchitomi, Y., Factors correlated with dyspnea in advanced lung cancer patients: organic causes and what else?. J Pain Symptom Manage 23 (2002), 490–500.
39. 39 Reddy, S.K., Parsons, H.A., Elsayem, A., Palmer, J.L., Bruera, E., Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 12 (2009), 29–36.
40. 40 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995), S78–S121.
41. 41 Nishimura, K., Izumi, T., Tsukino, M., Oga, T., Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121 (2002), 1434–1440.
42. 42 Habraken, J.M., terRiet, G., Gore, J.M., et al. Health-related quality of life in end-stage COPD and lung cancer patients. J Pain Symptom Manage 37 (2009), 973–981.
43. 43 Gore, J.M., Brophy, C.J., Greenstone, M.A., How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 55 (2000), 1000–1006.
44. 44 Bausewein, C., Booth, S., Gysels, M., et al. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 13 (2010), 1109–1118.